Blueprint for Transparency at the U.S. Food and Drug Administration: Recommendations to Advance the Development of Safe and Effective Medical Products

Bibliographische Detailangaben

Veröffentlicht in:	The Journal of law, medicine & ethics medicine & ethics, 2017-12, Vol.45 (4), p.S7
Hauptverfasser:	Sharfstein, Joshua M, Miller, James Dabney, Davis, Anna L, Ross, Joseph S, McCarthy, Margaret E, Smith, Brian, Chaudhry, Anam, Alexander, G. Caleb, Kesselheim, Aaron S
Format:	Artikel
Sprache:	eng
Schlagworte:	Company business management Drug approval Laws, regulations and rules Management Medical supplies Safety and security measures
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!